About Medtronic Plc 
Medtronic Plc
Pharmaceuticals & Biotechnology
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.
Company Coordinates 
Company Details
20 On Hatch, Hatch Street Lower , DUBLIN None : 2
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 244 Schemes (34.06%)
Foreign Institutions
Held by 526 Foreign Institutions (19.93%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Geoffrey Martha
Executive Chairman of the Board, President, Chief Executive Officer
Mr. Richard Anderson
Independent Director
Mr. Craig Arnold
Independent Director
Mr. Scott Donnelly
Independent Director
Ms. Andrea Goldsmith
Independent Director
Mr. Randall Hogan
Independent Director
Revenue and Profits:
Net Sales:
8,578 Million
(Quarterly Results - Jul 2025)
Net Profit:
1,047 Million
Pharmaceuticals & Biotechnology
USD 119,277 Million (Large Cap)
21.00
NA
3.08%
0.43
11.60%
2.49






